Ionis Pharmaceuticals (IONS) PT Raised to $64 at Needham & Company as ENDEAR Study Halted Early for Efficacy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. BRZE
3. CHYM
4. USO
5. QCOM
6. IRT
7. ASO
8. EVMN
9. AAPL
10. DYN

Go back to Ionis Pharmaceuticals (IONS) PT Raised to $64 at Needham & Company as ENDEAR Study Halted Early for Efficacy
(NASDAQ: IONS) Delayed: 55.99 -0.72 (1.27%)
Previous Close $56.71    52 Week High $62.68 
Open $56.38    52 Week Low $19.59 
Day High $56.96    P/E N/A 
Day Low $55.76    EPS $0.00 
Volume 597,713